2m 2m 2m 2m 2m 2m 2m
AN2 THERAPEUTIC (ANTX)
NASDAQ
$4.17+$0.10 (+2.48%)
Price as of Jun 03, 2026 5:53 PM EDT- $155.9MMarket Cap
- 270.00%1-Year Change
- BiotechnologyIndustry
AN2 THERAPEUTIC (ANTX)
$4.17+$0.10 (+2.48%)
ANTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.07 | ||
Change | -$0.14 (-3.33%) | ||
Open | $4.29 | ||
High | $4.46 | ||
Low | $4.01 | ||
Previous Close | $4.21 | ||
Volume | 176,449 | ||
30-Day Average Volume | 241,853 | ||
1-Week Change | -13.95% | ||
1-Month Change | -13.03% | ||
1-Year Change | 270.00% | ||
3-Year Change | -36.51% | ||
5-Year Change | -92.84% | ||
Fundamentals | |||
Shares Outstanding | 36.0M | ||
Total Assets | $87.5M | ||
Market Cap | $155.9M | ||
Enterprise Value | $102.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.0M | ||
Free Cash Flow | -$12.1M | ||
EBIT | -$10.0M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $81.9M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -15 | ||
PEG | 14 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 04/12/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue